Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome

International Journal of Gynecology and Obstetrics

Volumn 108, Issue 2, 2010, Pages 148-151

  Zhao, Xiaomiao ^a   Zhong, Junmin ^a   Mo, Yaqin ^a   Chen, Xiaoli ^a   Chen, Yaxiao ^a   Yang, Dongzi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hirsutism; Hyperandrogenemia; Obesity; Polycystic ovary syndrome; Type 2 diabetes

Indexed keywords

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; HIRSUTISM; HUMAN; HYPERANDROGENISM; INFERTILITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

EID: 73749084491     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.09.021     Document Type: Article

References (22)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 333 13 (1995) 853-861
2. Rotterdam ESHRE/ASRM-sponsored PCOC Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 1 (2004) 19-25
3. Hsu M.I., Liou T.H., Chou S.Y., Chang C.Y., and Hsu C.S. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 88 3 (2007) 727-729
4. Pehlivanov B., and Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol 23 10 (2007) 604-609
5. Diamanti-Kandarakis E., and Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 67 5 (2007) 735-742
6. Kauffman R.P., Baker T.E., Baker V.M., DiMarino P., and Castracane V.D. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol 198 6 (2008) 670 e671-7 (discussion 670 e677-10)
7. Chae S.J., Kim J.J., Choi Y.M., Hwang K.R., Jee B.C., Ku S.Y., et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 23 8 (2008) 1924-1931
8. Chang W.Y., Knochenhauer E.S., Bartolucci A.A., and Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 83 6 (2005) 1717-1723
9. Broekmans F.J., Knauff E.A., Valkenburg O., Laven J.S., Eijkemans M.J., and Fauser B.C. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113 10 (2006) 1210-1217
10. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91 11 (2006) 4237-4245
11. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 10 (2008) e3
12. Coviello A.D., Legro R.S., and Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91 2 (2006) 492-497
13. Schuring A.N., Schulte N., Sonntag B., and Kiesel L. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome. Gynakol Geburtshilfliche Rundsch 48 1 (2008) 9-15
14. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91 3 (2006) 781-785
15. Chen X., Yang D., Mo Y., Li L., Chen Y., and Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 139 1 (2008) 59-64
16. Zhao J.L., Chen Z.J., Shi Y.H., Geng L., Ma Z.X., Li Y., et al. Investigation of body hair assessment of Chinese women in Shandong region and its preliminary application in polycystic ovary syndrome patients. [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 42 9 (2007) 590-594
17. DeUgarte C.M., Woods K.S., Bartolucci A.A., and Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91 4 (2006) 1345-1350
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 31 Suppl 1 (2008) S55-S60
19. Welt C.K., Gudmundsson J.A., Arason G., Adams J., Palsdottir H., Gudlaugsdottir G., et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 91 12 (2006) 4842-4848
20. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 6 (2004) 2745-2749
21. Barber T.M., Wass J.A., McCarthy M.I., and Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 66 4 (2007) 513-517
22. Mercurio M.G., and Gogstetter D.S. Androgen physiology and the cutaneous pilosebaceous unit. J Gend Specif Med 3 4 (2000) 59-64